ArticleJAMA network open2021

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction.

Nicolas Isaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.